Clin2
NCT05897034Possibly a fitNot yet recruiting

Study antibiotics for untreated gonorrhea and chlamydia

Sexually Transmitted Diseases

Treatments studied

Part of Infections clinical trials.

This trial tests a combination of medications (doxycycline, pentoxifylline, and nitazoxanide) in men with untreated gonorrhea and chlamydia. It may help clear the infection more effectively, but you must meet specific safety and health criteria.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2/Phase 3
Enrollment
100 people
Ages
18 years to 60 years
Study type
Interventional

Who can take part

  • You are over 18 years old
  • You have gonorrhea and chlamydia confirmed by a diagnosis
  • You have not taken antibiotics for gonorrhea or chlamydia in the past 28 days
  • You do not have a known allergy or bad reaction to doxycycline, pentoxifylline, or nitazoxanide
  • Your infections do not involve complications like pelvic inflammatory disease or epididymis/testicle inflammation
  • You do not have severe kidney or liver failure

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06007534Recruiting
Doxycycline for STI Prevention After Sex

This study looks at how a single 200 mg dose of doxycycline works in the body to prevent bacterial sexually transmitted infections (like chlamydia, gonorrhea, and syphilis) after a risky sexual encounter. It is for men who have sex with men and are already on PrEP or living with HIV.

Paris
NCT07500415Recruiting
Doxycycline to prevent STIs in Rio de Janeiro

This trial tests whether taking the antibiotic doxycycline can prevent sexually transmitted infections (STIs) like chlamydia, gonorrhea, and syphilis in people at higher risk. If you are a man or transgender woman who has sex with men, are living with HIV or on PrEP, and have had an STI in the past year, you may be able to join.

Rio de Janeiro, Rio de Janeiro
NCT04762134Recruiting
Doxycycline to prevent future bacterial STIs in high-risk men

This trial tests whether taking doxycycline can lower the chance of getting bacterial sexually transmitted infections like syphilis, gonorrhea, and chlamydia. It is aimed at men who have had these infections recently and expect to keep having multiple male partners.

Calgary, Alberta
NCT06738407Recruiting· Phase 4
Doxycycline to prevent STIs in high-risk people

This study tests whether taking a daily antibiotic (doxycycline) can prevent sexually transmitted infections in people at high risk. If you've had an STI recently and sometimes have sex without condoms, you might be able to join.

Los Angeles, California
NCT07397403Recruiting· Phase 4
Doxycycline to prevent STIs in men who have sex with men

This trial tests whether taking a single dose of doxycycline after sex can prevent common sexually transmitted infections (STIs) like gonorrhea, chlamydia, and syphilis in men who have sex with men (MSM) in Bangkok.

Sathorn, Bangkok
NCT06468462Recruiting· Phase 4
Comparing STI prevention strategies for Kenyan men

This study tests two ways to prevent STIs in men who have sex with men in Kenya: taking antibiotics only when you have symptoms, or taking a single antibiotic pill (doxycycline) shortly after sex. It aims to find which approach works better for keeping you healthy.

Kisumu

Hear when a new Sexually Transmitted Diseases trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.